Cresset Asset Management LLC Increases Stock Holdings in Humana Inc. $HUM

Cresset Asset Management LLC boosted its stake in Humana Inc. (NYSE:HUM) by 1,736.8% during the third quarter, Holdings Channel.com reports. The fund owned 43,513 shares of the insurance provider’s stock after purchasing an additional 41,144 shares during the quarter. Cresset Asset Management LLC’s holdings in Humana were worth $11,359,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in HUM. Elevation Point Wealth Partners LLC purchased a new position in Humana during the second quarter valued at $32,000. Mather Group LLC. acquired a new position in shares of Humana during the 3rd quarter worth about $34,000. AlphaCore Capital LLC purchased a new position in Humana in the 2nd quarter valued at about $39,000. Private Wealth Management Group LLC boosted its holdings in Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after buying an additional 48 shares during the last quarter. Finally, SJS Investment Consulting Inc. increased its stake in Humana by 19,300.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock worth $50,000 after buying an additional 193 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Humana

In other Humana news, insider Sanjay K. Shetty acquired 810 shares of the firm’s stock in a transaction that occurred on Monday, February 23rd. The shares were purchased at an average cost of $185.21 per share, for a total transaction of $150,020.10. Following the completion of the acquisition, the insider owned 11,657 shares of the company’s stock, valued at approximately $2,158,992.97. The trade was a 7.47% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.37% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on HUM. The Goldman Sachs Group decreased their target price on Humana from $215.00 to $158.00 and set a “sell” rating on the stock in a research report on Friday, February 13th. Jefferies Financial Group reduced their price objective on Humana from $310.00 to $235.00 and set a “buy” rating for the company in a research note on Thursday, February 12th. TD Cowen lowered their target price on shares of Humana from $260.00 to $173.00 and set a “hold” rating on the stock in a research note on Friday, February 13th. Zacks Research cut shares of Humana from a “hold” rating to a “strong sell” rating in a research report on Thursday, January 1st. Finally, Wolfe Research raised their price target on shares of Humana from $300.00 to $325.00 and gave the stock an “outperform” rating in a research note on Thursday, January 8th. Seven research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, Humana currently has an average rating of “Hold” and a consensus target price of $225.48.

Humana Stock Down 1.4%

Shares of HUM opened at $180.50 on Friday. Humana Inc. has a 52-week low of $169.61 and a 52-week high of $315.35. The company has a quick ratio of 2.00, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The stock has a fifty day simple moving average of $223.34 and a two-hundred day simple moving average of $253.27. The company has a market capitalization of $21.77 billion, a PE ratio of 18.38, a price-to-earnings-growth ratio of 1.97 and a beta of 0.44.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm had revenue of $32.64 billion during the quarter, compared to analyst estimates of $32.08 billion. During the same quarter in the prior year, the firm posted ($2.16) earnings per share. Humana’s quarterly revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, equities analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 2.0%. Humana’s dividend payout ratio (DPR) is currently 36.05%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.